Cold weather, dry air, an overactive immune system or our modern lifestyle. The causes may vary, but an increasing number of ...

The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects ...

Biolumpivaxin will help in disease surveillance as it means the experts will be able to distinguish between vaccinated and ...

Biovet, a part of Bharat Biotech, has received approval to market Biolumpvaxin, a groundbreaking DIVA marker vaccine for lumpy skin disease in cattle and buffaloes. The launch of this vaccine marks a ...